Multiple dose of liquid antacid enhance simvastatin bioavailability in Malaysian male volunteers

Khaled M Al Akhali, Sirajudeen S Alavudeen

Abstract


The effect of a liquid antacid on the oral bioavailability of simvastatin 40 mg tablet was evaluated in 9 healthy Malaysian
male volunteers in a randomized, single dose, two‑way crossover study. The drug was administered following an overnight
fast or a liquid antacid. The plasma concentration of simvastatin was determined by using a validated HPLC-MS-MS method.
An effect of liquid antacid on the bioavailability was indicated 95% increase in the AUC of simvastatin with antacid state
comparing to fasting state. The study was concluded that liquid antacid had effect on the increasing pH of gastrointestinal
tract which leads to increasing the lactone form of simvastatin stability and improve the dissolution of the drug by increasing
gastric residence time. This study revealed that simvastatin is pH‑dependent.
Key words: Liquid antacid, fasting, simvastatin bioavailability

Full Text:

PDF

References


Gibaldi M. Biopharmaceutical and Clinical Pharmacokinetics. 3rd ed.

Lea and Febiger: Philadelphia; 1991. p . 102‑20.

Hurwitz A, Sheehan BM. The effects of antacids on the absorption

of orally administered pentobarbital in the rat. J Pharmacol Exp Ther

;179:124‑31.

al‑Gohary OM, Hosny EA. Effect of antacid magaldrate oral suspension

on in‑vitro and in‑vivo availability of indomethacin in dogs. Pharm Acta

Helv 1997;72:8l‑6.

Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The influence of excipients

on the diffusion of ibuprofen and paracetamol in gastric mucus. Inter

J Pharm 2005;290:145‑54.

Fann WE, Davis JM, Janowsky DS, Sekerke HJ, Schmidt DM.

Chlorpromazine: Effects of antacids on its gastrointestinal absorption.

J Clin Pharmacol 1973;13:388‑90.

Chun AH, Carrigan PJ, Hoffman DJ, Kershner RP, Stuart JD. Effect of antacid

on absorption of clorazepate. Clin Pharmacol Ther 1977;22:329‑35.

Galeazzi RL. The effect of an antacid on the bioavailability of

indomethacin. Eur J Clin Pharmacol 1977;12:65‑8.

Gugler R, Brand M, Somogyi A. Impaired cimetidine absorption due to

antacids and metoclopramide. Eur J Clin Pharmacol 1981;20:225‑8.

Greenblatt DJ, Shader RI, Harmatz JS, Franke K, Koch‑Weser J. Influence

of magnesium and aluminum hydroxide mixtures on chlordiazepoxide

absorption. Clin Pharmacol Ther 1976;19:234‑9.

Albin H, Demotes‑Mainard F, Vinçon G, Bedjaoui A, Begaud B. Effect of

two antacids on the bioavailability of paracetamol. Eur J Clin Pharmacol

;29:251‑3.

Blouin RA, Kneer J, Ambros RJ, Stoeckel K. Influence of antacid and

ranitidine on the pharmacokinetics of oral cefetamet pivoxil. Antimicrob

Agents Chemother 1990;34:1744‑8.

Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT, Nix DE.

Pharmacokinetics of pyrazinamide under fasting conditions, with food

and with antacid. Pharmacotherapy 1998;18:1205‑11.

Ambre JJ, Fischer LJ. Effect of co‑administration of aluminum and

magnesium hydroxides on absorption of anticoagulants in man. Clin

Pharmacol Ther 1973;14:231‑7.

Sommers DK, van Wyk M, Moncrieff J, Schoeman HS. Influence of food

and reduced gastric acidity on the bioavailabity of bacampicillin and

cefuroxime axetil. Br J Clin Pharmacol 1984;18:535‑9.

Hughes GS, Heald DL, Barker KB, Patel RK, Spillers CR, Watts KC, et al.

The effects of gastric pH and food on the pharmacokinetics of a new oral

cephalosporin, cefpodoximeproxetil. Clin Pharmacol Ther 1989;46:674‑85.

Plosker LG, Mctavish D. Simvastatin. A reappraisal of its pharmacology and

therapeutic efficacy in hypercholesterolanemia. Drugs 1995;50:334‑63.

Garrett ER, Won CM. Prediction of stability in pharmaceutical

preparations. XVI. Kinetics of hydrolysis of canrenone and lactonization

of canrenoic acid. J Pharm Sci 1971;60:1801‑9.

Kaufman MJ. Rate and equilibrium constants for acid‑catalyzed lactone

hydrolysis of HMG‑CoA reductase inhibitors. Inter J Pharm 1990;66:97‑106.

Serajuddin AT, Ranadive SA, Mahoney EM. Relative lipophilicities,

solubilities, and structure pharmacological considerations of

‑HMG‑CoA reductase inhibitors pravastatin, lovastatin, mevastatin,

and simvastatin. J Pharm Sci 1991;80:830‑4.

Mayersohn M. Physiological factors that modify systemic drug

availability and pharmacologic response in clinical practice. In:

Blanchard J, Sawchuk RJ, Brodie BB, editors. Principles and perspectives

in drug bioavailability. Switzerland by Boehm AG, basal; 1979. P . 211‑73.

Fleisher D, Li C, Zhou Y, Pao LH, Karim A. Drug, meal and formulation

interactions influencing drug absorption after oral administration. Clin

Pharmacokinet 1999;36:233‑54.

Amidon GL, Lennernäs H, Shah VP, Crison JR. A theorical basis for a

biopharmaceutic drug classification: The correlation of in vitro product

dissolution and in vivo bioavailability. Pharm Res 1995;12:413‑20.

Gault H, Kalra J, Ahmed M, Kepkay D, Barrowman J. Influence of

gastric pH on digoxin biotransformationI. Intra‑gastric hydrolysis. Clin

Pharmacol Ther 1980;27:16‑21.

Gault H, Kalra J, Ahmed M, Kepkay D, Longerich L, Barrowman J.

Influence of gastric pH on digoxin biotransformation II. Extractable

urinary metabolites. Clin Pharmacol Ther 1981;29:181‑90.

Hou JP, Poole JW. Kinetics and mechanism of degradation of ampicillin

in solution. J Pharm Sci 1969;58:447‑54.

Cooke AR, Hunt JN. Absorption of acetylsalicylic acid from unbuffered

and buffered gastric contents. Am J Dig Dis 1970;15:95‑102.

Mauro VF. Clinical pharmacokinetics and practical applications of

simvastatin. J Clin Pharmacokinet 1993;24:195‑202.

Russell TL, Berardi RR, Barnett JL, Dermentzoglou LC, Jarvenpaa KM,

Schmaltz SP, et al. Upper Gastrointestinal pH in seventy‑nine healthy,

elderly, north american men and women. J Pharm Res 1993;10:187‑96.

Saku K, Sasaki J, Arakawa K. Low dose effect of simvastatin (MK‑733)

on serum lipids, lipoproteins, and apolipoproteins in patients with

hypercholesterolemia. J Clin Ther 1989;11:247‑57.

Todd PA, Goa KL. Simvastatin. A review of its pharmacological

properties and Therapeutic Potential in Hypercholesterolaemia. Drugs

;40:583‑607.




DOI: http://dx.doi.org/10.22377/ajp.v8i2.344

Refbacks

  • There are currently no refbacks.